↓ Skip to main content

Cochrane Database of Systematic Reviews

Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS

Overview of attention for article published in Cochrane database of systematic reviews, March 2013
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
157 Mendeley
Title
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
Published in
Cochrane database of systematic reviews, March 2013
DOI 10.1002/14651858.cd005481.pub3
Pubmed ID
Authors

Muki S Shey, Eugene J Kongnyuy, Samuel M Alobwede, Charles S Wiysonge

Abstract

UNAIDS estimates that 34 million people are currently living with the human immunodeficiency virus (HIV) worldwide. Currently recommended regimens for initiating HIV treatment consist of either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or ritonavir-boosted protease inhibitor (PI) combined with two nucleoside reverse transcriptase inhibitors (NRTIs). However, there may be some patients for whom NNRTIs and PIs may not be appropriate. This is an update of the review published in the Cochrane Library Issue 3, 2009.

Timeline
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 155 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 13%
Student > Master 20 13%
Researcher 18 11%
Student > Ph. D. Student 13 8%
Student > Doctoral Student 8 5%
Other 33 21%
Unknown 44 28%
Readers by discipline Count As %
Medicine and Dentistry 48 31%
Psychology 11 7%
Nursing and Health Professions 9 6%
Social Sciences 8 5%
Unspecified 7 4%
Other 26 17%
Unknown 48 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2013.
All research outputs
#18,157,518
of 26,563,001 outputs
Outputs from Cochrane database of systematic reviews
#11,709
of 13,244 outputs
Outputs of similar age
#138,233
of 212,908 outputs
Outputs of similar age from Cochrane database of systematic reviews
#180
of 209 outputs
Altmetric has tracked 26,563,001 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,244 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,908 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 209 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.